Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Clinical Trials 94
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 87
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,382 Results (Page 40 of 120)
- Relevance
  Sort by

Rheumatoid Arthritis Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

 Report
September 2025
96 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Alpha 1 Adrenergic Receptor Antagonist - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1308EUR$1,500USD£1,140GBP

Antiplatelet Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
104 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Immune Thrombocytopenic Purpura Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
94 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Recurrent Glioblastoma Multiform Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2022
Global

From

€3500EUR$4,298USD£3,155GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Schizophrenia Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2022
85 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
November 2023
1129 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

 Report
December 2024
125 Pages
Global

From

€4056EUR$4,650USD£3,533GBP

Pharmaceutical Marketing Market - Global Forecast 2026-2032

 Report
January 2026
188 Pages
Global

From

€3436EUR$3,939USD£2,992GBP

Cervical Cancer Treatment - Global Strategic Business Report

 Report
February 2026
372 Pages
Global

From

€5103EUR$5,850USD£4,444GBP

Vitiligo Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
August 2024
81 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Ulcerative Colitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

 Report
March 2025
99 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1090EUR$1,250USD£950GBP

Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
200 Pages
Global

From

€6542EUR$7,500USD£5,698GBP

Biosimilars Market Industry Trends and Global Forecasts to 2035 - Distribution by Drug Class, Therapeutic Area, Type of Manufacturer, Distribution Channel, Geographical Regions and Leading Players

 Report
November 2024
319 Pages
Global

From

€4186EUR$4,799USD£3,646GBP

Neurology Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

 Report
March 2023
118 Pages
Global

From

€3925EUR$4,500USD£3,419GBP

Glioblastoma Multiform Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2022
78 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Systemic Lupus Erythematosus Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
89 Pages
Global

From

€3500EUR$4,298USD£3,155GBP

Liver Cancer Therapeutics Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4317EUR$4,949USD£3,760GBP

Hepatocellular Carcinoma - Global Clinical Trials Review, 2023

 Clinical Trials
December 2023
2557 Pages
Global

From

€2181EUR$2,500USD£1,899GBP

2,382 Results (Page 40 of 120)
- 1
- 38
- 39
- 40
- 41
- 42

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.